LCM
BIOSU

Lynwood Capital Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Lynwood Capital Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,000
Closed -$250K – 162
2021
Q4 		$250K Buy
+25,000
New +$250K 0.24% 78

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lynwood Capital Management's BIOSU Position: Q1 2022 in Review

Lynwood Capital Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q1 2022, closing a stake of 25,000 shares — an estimated $250K sold.

Lynwood Capital Management first reported a position in BIOSU in Q4 2021 and held it in 1 quarter. The position peaked at $250K in Q4 2021. 30 funds tracked by Wall St. Rank hold BIOSU as of Q1 2022.

  • Lynwood Capital Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • Lynwood Capital Management sold 25,000 BioPlus Acquisition Corp. Unit shares in Q1 2022, an estimated $250K.
  • Lynwood Capital Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • Lynwood Capital Management's BioPlus Acquisition Corp. Unit position peaked at $250K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q1 2022.

Based on Lynwood Capital Management's 13F filing for Q1 2022, filed 5 May 2022.